CY2431B1 - Novel phenanthridines substituted in the 6 position. - Google Patents

Novel phenanthridines substituted in the 6 position.

Info

Publication number
CY2431B1
CY2431B1 CY0400018A CY0400018A CY2431B1 CY 2431 B1 CY2431 B1 CY 2431B1 CY 0400018 A CY0400018 A CY 0400018A CY 0400018 A CY0400018 A CY 0400018A CY 2431 B1 CY2431 B1 CY 2431B1
Authority
CY
Cyprus
Prior art keywords
novel
substituted
phenanthridines substituted
novel phenanthridines
compounds
Prior art date
Application number
CY0400018A
Inventor
Hermann Amschler
Dieter Flockerzi
Wolf-Ruediger Ulrich
Thomas Baer
Thomas Martin
Christian Schudt
Armin Hatzelmann
Rolf Beume
Dietrich Haefner
Hildegard Boss
Hans-Peter Kley
Beate Gutterer
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996113091 external-priority patent/DE19613091A1/en
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2431B1 publication Critical patent/CY2431B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Abstract

Compounds of formula (I) in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings given in the description, are novel effective bronchial therapeutic agents.
CY0400018A 1996-03-26 2004-03-12 Novel phenanthridines substituted in the 6 position. CY2431B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19611922 1996-03-26
EP96105038 1996-03-29
DE1996113091 DE19613091A1 (en) 1996-04-02 1996-04-02 New 6-substituted phenanthridine derivatives
EP96105311 1996-04-03

Publications (1)

Publication Number Publication Date
CY2431B1 true CY2431B1 (en) 2004-11-12

Family

ID=27438318

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400018A CY2431B1 (en) 1996-03-26 2004-03-12 Novel phenanthridines substituted in the 6 position.

Country Status (12)

Country Link
EP (1) EP0889886B1 (en)
JP (1) JP4141501B2 (en)
AT (1) ATE224386T1 (en)
AU (1) AU718752B2 (en)
CA (1) CA2250569C (en)
CY (1) CY2431B1 (en)
DE (1) DE59708265D1 (en)
DK (1) DK0889886T5 (en)
ES (1) ES2184077T3 (en)
PT (1) PT889886E (en)
SI (1) SI0889886T1 (en)
WO (1) WO1997035854A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1000035B1 (en) * 1997-07-25 2002-11-27 ALTANA Pharma AG Substituted 6-phenylphenanthridines
WO1999005111A1 (en) * 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel tetrazole derivatives
AR015966A1 (en) * 1997-10-17 2001-05-30 Smithkline Beecham Corp USE OF A PDE4 INHIBITOR COMPOUND FOR THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR PRURITE TREATMENT
IT1296985B1 (en) * 1997-12-19 1999-08-03 Zambon Spa BENZAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4
PT1147087E (en) * 1999-01-15 2005-09-30 Altana Pharma Ag FEANTRIDINE-N-OXIDES WITH PDE-IV INHIBITION ACTIVITY
CA2359449A1 (en) * 1999-01-15 2000-07-20 Beate Gutterer Phenanthridine-n-oxides with pde-iv inhibiting activity
WO2000042018A1 (en) * 1999-01-15 2000-07-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
EP1147088B1 (en) * 1999-01-15 2006-01-04 ALTANA Pharma AG 6-arylphenanthridines with pde-iv inhibiting activity
DK1147089T3 (en) * 1999-01-15 2006-04-10 Altana Pharma Ag Phenylphenanthridines with PDE-IV inhibitory effect
ATE320800T1 (en) 1999-08-21 2006-04-15 Altana Pharma Ag SYNERGISTIC COMBINATION OF ROFLUMILAST AND SALMETEROL
AU782908B2 (en) * 2000-01-11 2005-09-08 Altana Pharma Ag Phenanthridine-N-oxides
AU2001281965A1 (en) * 2000-07-14 2002-01-30 Byk Gulden Lomberg Chemische Fabrik G.M.B.H. Novel 6-phenylphenanthridines
EP1303506B1 (en) * 2000-07-14 2005-02-02 ALTANA Pharma AG 6-heteroarylphenanthridines
WO2002006239A1 (en) * 2000-07-14 2002-01-24 Altana Pharma Ag Phenanthridine n-oxides
WO2002006238A1 (en) * 2000-07-14 2002-01-24 Altana Pharma Ag Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
CA2496459C (en) 2002-08-29 2013-06-25 Altana Pharma Ag 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
US7329676B2 (en) 2002-08-29 2008-02-12 Nycomed Gmbh 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
JP2007500686A (en) * 2003-07-31 2007-01-18 アルタナ　ファルマ　アクチエンゲゼルシャフト Novel 6-phenylphenanthridine
EP1658270A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenantridines
AU2005212857B2 (en) 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
EA014155B1 (en) 2004-03-03 2010-10-29 Никомед Гмбх Novel hydroxy -6-heteroarylphenanthridines and their use as pde4 inhibitors
AU2005220034A1 (en) * 2004-03-09 2005-09-15 Nycomed Gmbh Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
EP1725532A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
EP1725533A1 (en) * 2004-03-10 2006-11-29 Altana Pharma AG Novel thio containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
AU2006210231A1 (en) 2005-02-01 2006-08-10 Nycomed Gmbh Novel 6-pyridylphenanthridines
AU2006219862A1 (en) * 2005-03-02 2006-09-08 Nycomed Gmbh 6-Heteroaryl-1,2,3,4,4a, 10b-hexahydro-phenanthridines as PDE-4 inhibitors for the treatment of inflammatory disorders
NZ589278A (en) 2005-03-02 2012-04-27 Nycomed Gmbh Selected salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
WO2007027651A2 (en) * 2005-08-30 2007-03-08 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
UY35543A (en) * 2013-04-30 2014-11-28 Bayer Cropscience Ag N- (PHENYLCYCALALKYL) CARBOXAMIDS AND N- (PHENYLCICLOALKYL) NEMATICIDED THIOCARBOXAMIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786031A (en) * 1971-07-08 1973-01-08 Rhone Poulenc Sa NEW DERIVATIVES OF PHENANTHRIDIN, THEIR PREPARATION AND THE MEDICINAL COMPOSITIONS CONTAINING THEM
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Also Published As

Publication number Publication date
DE59708265D1 (en) 2002-10-24
WO1997035854A1 (en) 1997-10-02
EP0889886B1 (en) 2002-09-18
CA2250569A1 (en) 1997-10-02
CA2250569C (en) 2005-05-10
PT889886E (en) 2003-02-28
ES2184077T3 (en) 2003-04-01
AU718752B2 (en) 2000-04-20
AU2291097A (en) 1997-10-17
EP0889886A1 (en) 1999-01-13
JP2000507256A (en) 2000-06-13
JP4141501B2 (en) 2008-08-27
ATE224386T1 (en) 2002-10-15
DK0889886T5 (en) 2003-02-24
DK0889886T3 (en) 2003-01-20
SI0889886T1 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
CY2473B1 (en) New phenanthridines.
MX9700557A (en) Dihydrobenzofuranes.
PL338339A1 (en) Novel derivatives of tetrazole
CA2297911A1 (en) Substituted 6-phenylphenanthridines
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
MD502G2 (en) New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof
CY2582B2 (en) New imidazopyridines and oxazolopyridines
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
TR199701011A2 (en) 1-carb-(detia)-cephalosporin t�revleri.